196 related articles for article (PubMed ID: 36702193)
1. TFR2 regulates ferroptosis and enhances temozolomide chemo-sensitization in gliomas.
Tong S; Hong Y; Xu Y; Sun Q; Ye L; Cai J; Ye Z; Chen Q; Tian D
Exp Cell Res; 2023 Mar; 424(1):113474. PubMed ID: 36702193
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA ATXN8OS promotes ferroptosis and inhibits the temozolomide-resistance of gliomas through the ADAR/GLS2 pathway.
Luo J; Bai R; Liu Y; Bi H; Shi X; Qu C
Brain Res Bull; 2022 Aug; 186():27-37. PubMed ID: 35460867
[TBL] [Abstract][Full Text] [Related]
3. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species.
Bi Y; Li H; Yi D; Bai Y; Zhong S; Liu Q; Chen Y; Zhao G
Cancer Lett; 2018 Oct; 435():66-79. PubMed ID: 30081068
[TBL] [Abstract][Full Text] [Related]
4. The RNA-binding protein fragile-X mental retardation autosomal 1 (FXR1) modulates glioma cells sensitivity to temozolomide by regulating ferroptosis.
Wei Y; Duan S; Gong F; Li Q
Biochem Biophys Res Commun; 2022 May; 603():153-159. PubMed ID: 35294905
[TBL] [Abstract][Full Text] [Related]
5. LINC01564 Promotes the TMZ Resistance of Glioma Cells by Upregulating NFE2L2 Expression to Inhibit Ferroptosis.
Luo C; Nie C; Zeng Y; Qian K; Li X; Wang X
Mol Neurobiol; 2022 Jun; 59(6):3829-3844. PubMed ID: 35420382
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of temozolomide on glioma cells is sensitized by RSL3-induced ferroptosis but negatively correlated with expression of ferritin heavy chain 1 and ferritin light chain.
Yang FC; Wang C; Zhu J; Gai QJ; Mao M; He J; Qin Y; Yao XX; Wang YX; Lu HM; Cao MF; He MM; Wen XM; Leng P; Cai XW; Yao XH; Bian XW; Wang Y
Lab Invest; 2022 Jul; 102(7):741-752. PubMed ID: 35351965
[TBL] [Abstract][Full Text] [Related]
7. Mutant IDH1 Enhances Temozolomide Sensitivity via Regulation of the ATM/CHK2 Pathway in Glioma.
Lin L; Cai J; Tan Z; Meng X; Li R; Li Y; Jiang C
Cancer Res Treat; 2021 Apr; 53(2):367-377. PubMed ID: 33070553
[TBL] [Abstract][Full Text] [Related]
8. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
Li C; Feng S; Chen L
Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
[TBL] [Abstract][Full Text] [Related]
9. p53 Promoted Ferroptosis in Ovarian Cancer Cells Treated with Human Serum Incubated-Superparamagnetic Iron Oxides.
Zhang Y; Xia M; Zhou Z; Hu X; Wang J; Zhang M; Li Y; Sun L; Chen F; Yu H
Int J Nanomedicine; 2021; 16():283-296. PubMed ID: 33469287
[TBL] [Abstract][Full Text] [Related]
10. Honokiol enhances temozolomide-induced apoptotic insults to malignant glioma cells via an intrinsic mitochondrion-dependent pathway.
Chio CC; Tai YT; Mohanraj M; Liu SH; Yang ST; Chen RM
Phytomedicine; 2018 Oct; 49():41-51. PubMed ID: 30217261
[TBL] [Abstract][Full Text] [Related]
11. TXNDC12 knockdown promotes ferroptosis by modulating SLC7A11 expression in glioma.
Yu H; Zhu K; Wang M; Jiang X
Clin Transl Sci; 2023 Oct; 16(10):1957-1971. PubMed ID: 37503932
[TBL] [Abstract][Full Text] [Related]
12. Temozolomide Drives Ferroptosis via a DMT1-Dependent Pathway in Glioblastoma Cells.
Song Q; Peng S; Sun Z; Heng X; Zhu X
Yonsei Med J; 2021 Sep; 62(9):843-849. PubMed ID: 34427071
[TBL] [Abstract][Full Text] [Related]
13. High levels of NRF2 sensitize temozolomide-resistant glioblastoma cells to ferroptosis via ABCC1/MRP1 upregulation.
de Souza I; Monteiro LKS; Guedes CB; Silva MM; Andrade-Tomaz M; Contieri B; Latancia MT; Mendes D; Porchia BFMM; Lazarini M; Gomes LR; Rocha CRR
Cell Death Dis; 2022 Jul; 13(7):591. PubMed ID: 35803910
[TBL] [Abstract][Full Text] [Related]
14. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
15. LRRC8A potentiates temozolomide sensitivity in glioma cells via activating mitochondria-dependent apoptotic pathway.
Yang C; He L; Chen G; Ning Z; Xia Z
Hum Cell; 2019 Jan; 32(1):41-50. PubMed ID: 30426452
[TBL] [Abstract][Full Text] [Related]
16. LncRNA UCA1/miR-182-5p/MGMT axis modulates glioma cell sensitivity to temozolomide through MGMT-related DNA damage pathways.
Cheng M; Wang Q; Chen L; Zhao D; Tang J; Xu J; He Z
Hum Pathol; 2022 May; 123():59-73. PubMed ID: 35219686
[TBL] [Abstract][Full Text] [Related]
17. Acquisition of chemoresistance in gliomas is associated with increased mitochondrial coupling and decreased ROS production.
Oliva CR; Moellering DR; Gillespie GY; Griguer CE
PLoS One; 2011; 6(9):e24665. PubMed ID: 21931801
[TBL] [Abstract][Full Text] [Related]
18. Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression through multiple pathways and enhances temozolomide resistance in glioma.
Ding C; Yi X; Chen X; Wu Z; You H; Chen X; Zhang G; Sun Y; Bu X; Wu X; Lin Z; Gu J; Lin Y; Kang D
J Exp Clin Cancer Res; 2021 May; 40(1):164. PubMed ID: 33975615
[TBL] [Abstract][Full Text] [Related]
19. Pseudolaric acid B triggers ferroptosis in glioma cells via activation of Nox4 and inhibition of xCT.
Wang Z; Ding Y; Wang X; Lu S; Wang C; He C; Wang L; Piao M; Chi G; Luo Y; Ge P
Cancer Lett; 2018 Aug; 428():21-33. PubMed ID: 29702192
[TBL] [Abstract][Full Text] [Related]
20. Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis.
Sehm T; Rauh M; Wiendieck K; Buchfelder M; Eyüpoglu IY; Savaskan NE
Oncotarget; 2016 Nov; 7(46):74630-74647. PubMed ID: 27612422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
